The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Cold atmospheric plasma technology is expected to become an option for adjuvant therapy in cancer due to its promising anticancer effect. Here, we evaluated the effects of different combinations of He+O2 plasma jet and clinical anticancer drug, doxorubicin, on A375 melanoma cells in vitro. The results show that the synergistic anticancer effect of plasma jet and doxorubicin is dependent on the manner...